---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-029521"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2023-04-13T23:59:59+00:00"
generated_at: "2026-06-17T02:36:30.466269+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Adial Pharmaceuticals stockholders approve reverse stock split range of 1:2 to 1:50

## Summary
- Approved amendment to Certificate of Incorporation to effect reverse stock split at Board's discretion within 1:2 to 1:50 range.
- Votes: 16,585,304 for, 2,050,482 against, 28,565 abstentions; broker non-votes not applicable.
- Board has one year from April 12, 2023 to implement or authority terminates.
- Adjournment proposal also approved but not needed as Proposal 1 passed.

## SEC filing metadata
- accession: 0001213900-23-029521
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2023-04-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390023029521/0001213900-23-029521-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390023029521/ea176887-8k_adialpharm.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-029521
- JSON: https://secwatch.observer/filing/0001213900-23-029521.json
- Plain text: https://secwatch.observer/filing/0001213900-23-029521.txt

## Key facts
- Shareholder Votes
  ADIAL PHARMACEUTICALS, INC. shareholders approved Approval of an adjournment of the Special Meeting to a later date, if necessary, to permit further solicitation and vote of proxies at the 2023-04-12 meeting.
  - Outcome: passed
  - Meeting: 2023-04-12
  source text: The stockholders approved Proposal 2 based on the votes listed below: Votes For Votes Against Abstentions Broker Non-Votes 17,465,868 1,135,263 63,222 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1513525/000121390023029521/0001213900-23-029521-index.htm
- Shareholder Votes
  ADIAL PHARMACEUTICALS, INC. shareholders approved Approval of an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio in the range of 1-for-2 to 1-for-50 at the 2023-04-12 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-04-12
  source text: The stockholders approved Proposal 1 to amend the Certificate of Incorporation based on the votes listed below: Votes For Votes Against Abstentions Broker Non-Votes 16,585,304 2,050,482 28,565 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1513525/000121390023029521/0001213900-23-029521-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.